( ornia. Applied Biosy...)Automated Fluorescent-Tag Cycle Sequencing
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Automated Fluorescent-Tag Cycle Sequencing
ornia.
Applied Biosystems. (1993/1994) In ABI Product Catalog, p.144. Foster City, California.
Applied Biosystems. (1995) In ABI PRISM, Comparative PCR Sequencing, p. 18. Foster City, California.
'"/>
Source:
Related biology technology :
1. Purified Single-Stranded M13 DNA for Automated Sequencing
2. CastAway Precast Gels for Rapid Automated DNA Sequence Analysis
3. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
4. Agilent 2100 Bioanalyzer Automated Analysis System
5. Automated RNA Amplification for Arrays
6. Quantitation of DNA for Automated Sequencing Using the VersaFluor Fluorometer
7. Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A
8. Total RNA Purification from Cultured Cells Using the ABI PRISM 6700 Automated Nucleic Acid Workstation and Total RNA Lysis Reagents
9. DNA Damage and Repair - Quantification of Sub-Cellular Events Using Automated Confocal Imaging
10. Small-Molecule Quantitation Using Automated Single-Shot Averaging MALDI-TOF Mass Spectrometry
11. Automated Dissolution of Prednisone with the MultiDose G3
Post Your Comments:
Breaking Biology Technology:Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6Sirius Genomics Announces Change in Leadership 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4
[0] Quest Diagnostics Declares Quarterly Cash Dividend[0] Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain[0] Sirius Genomics Announces Change in Leadership[0] Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea
Breaking Biology News(10 mins):Experts: Disease-resistant plants enhance profits, client satisfaction 2Copying mother nature's designs 2University of California, San Francisco, researcher receives ASBMB-Merck Award 2Who Says a Gym Membership Cant Be Free 3F Wexer is Redefining the Fitness Industry 49640 1Who Says a Gym Membership Cant Be Free 3F Wexer is Redefining the Fitness Industry 49640 2Common Weight Loss Surgery May Double Risk of Kidney Stones 49638 1Common Weight Loss Surgery May Double Risk of Kidney Stones 49638 2Crown Consumer Brands Re Launches DentaBurst 28TM 29 Freshening Teeth Cleaners 49636 1Crown Consumer Brands Re Launches DentaBurst 28TM 29 Freshening Teeth Cleaners 49636 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |